0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Stem Cell Transplant"

From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$7,500USDGBP
From
EUR$3,950USDGBP
Graft Versus Host Disease (GvHD) Treatment Market - Product Thumbnail Image

Graft Versus Host Disease (GvHD) Treatment Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
Stem Cells Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Stem Cells Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
From
EUR$4,450USDGBP
From
EUR$3,495USDGBP
From
EUR$4,949USDGBP
Transplantation Market Report and Forecast 2023-2031 - Product Thumbnail Image

Transplantation Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
EUR$4,949USDGBP
From
EUR$4,500USDGBP
Loading Indicator

The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions. The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more